When: May 20-22, 2025
Where: Philadelphia, Pennsylvania
Douglas CDMO will be showcasing how it supports pharmaceutical companies throughout the product development lifecycle.
Reach out to schedule a meeting with Susan Lynch-Smith, “Synergizer Sue”, Head of Business Development CDMO.
With extensive experience in developing and manufacturing a variety of dosage forms, and deep specialist expertise in high-potency softgel and liquid formulations, Douglas CDMO brings world-class knowledge and reputable high-quality standards to the table. We look forward to demonstrating our capabilities and fielding your questions on how we can support your product development.
For more information or to register for this event, please see the event website.
Susan Lynch-Smith, Head of Business Development, Douglas CDMO
Find out more about CPHI Americas
Learn moreOther posts you may be interested in...
Articles
Bespoke client solutions: A personalized approach as a privately owned CDMO
Douglas CDMO is making its mark in the pharmaceutical development industry with their flexible and personalized approaches to client needs.
Learn MoreArticles
Smart softgels: driving innovation in pharma
In the dynamic landscape of pharmaceuticals, one innovation has consistently pushed the boundaries of drug delivery: the softgel capsule.
Learn MoreCase Studies
Seizing market share pre-patent expiry: Navigating a paragraph IV ANDA submission
Douglas CDMO partnered with a US pharmaceutical firm to develop a cutting-edge generic isotretinoin softgel, overcoming regulatory and technical complexities, launching with remarkable success.
Learn More